Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

21.4%

6 terminated/withdrawn out of 28 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

83%

15 of 18 completed trials have results

Key Signals

3 recruiting15 with results

Enrollment Performance

Analytics

N/A
19(90.5%)
Phase 3
1(4.8%)
Phase 2
1(4.8%)
21Total
N/A(19)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT06997549Recruiting

Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Role: lead

NCT06917339Recruiting

Retrospective Analyses of TrakStar Database

Role: lead

NCT07147218Not ApplicableRecruiting

Accelerated TMS for MDD

Role: lead

NCT02586688Not ApplicableCompleted

Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents

Role: lead

NCT06429748Not ApplicableActive Not Recruiting

Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation

Role: lead

NCT02441985Not ApplicableCompleted

rTMS Therapy for Primary Orthostatic Tremor

Role: collaborator

NCT01415154Not ApplicableCompleted

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

Role: lead

NCT05535062Not ApplicableCompleted

Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature

Role: lead

NCT01842542Not ApplicableTerminated

Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset

Role: lead

NCT06699940Completed

A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents

Role: lead

NCT03363919Not ApplicableCompleted

Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression

Role: collaborator

NCT02542839Not ApplicableCompleted

rTMS and Botulinum Toxin in Primary Cervical Dystonia

Role: collaborator

NCT01701284Not ApplicableCompleted

Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety

Role: collaborator

NCT02131129Not ApplicableCompleted

rTMS in First Episode Psychosis

Role: collaborator

NCT05541302Completed

Retrospective TMS Therapy for Adults With MDD

Role: lead

NCT04217837Withdrawn

Treatment of Major Depressive Disorder in the UK Using TMS Therapy

Role: lead

NCT01718730Completed

Cortical Excitability and Inhibition in MDD

Role: collaborator

NCT02273063Not ApplicableCompleted

rTMS for PTSD Comorbid With Major Depressive Disorder

Role: collaborator

NCT02466230Not ApplicableCompleted

Antidepressant Mechanisms of Transcranial Magnetic Stimulation

Role: collaborator

NCT01900314Not ApplicableCompleted

Imaging Biomarkers for TMS Treatment of Depression

Role: collaborator